Complex Chromosomal Rearrangement der(5)ins(5;3)(q31;q25q29), t(3;12)(q24;p12.2) In A Dysmorphic Child, - A Case Report
Abstract
Complex chromosome rearrangements (CCRs) are structural aberrations or rearrangements involving three or more cytogenetics breakpoints on two or more chromosomes [1]. Balanced and unbalanced are known to have significant risk of mental retardation and phenotypic anomalies. CCRs are also associated with infertility in males and recurrent abortion in females. Here we report one case of apparently balanced CCR involving three chromosomes 3, 5 and 12 in a child with abnormal features. G banding and FISH were performed to clarify the nature of this complex abnormality.
The proband was a 3 years old Malay girl, referred for cytogenetic analysis due to abnormal features. She was very short at 5th centile, has triangular facies, strabismus, short neck and had significant delay in speech. Blood investigations including full blood count, serum amino acid, renal, liver and thyroid function tests were normal. There was no history of mental retardation, congenital malformation, or recurrent miscarriages in either family. Peripheral blood lymphocytes of the proband was cultured and chromosome preparations were made as per standard procedures. Karyotype analysis was carried out based on ISCN (2016). Fluorescence in situ hybridisation (FISH) technique was carried out using Whole Chromosome Painting Probes (WCP) for chromosome 3, 5 and 12 as per standard procedures. Cytogenetic analysis on 32 GTG banded metaphases at the resolution level of 400-550 bphs showed 46,XX,der(5)ins(5;3)(q31;q25q29),t(3;12)(q24;p12.2) complex karyotype pattern (Figure 1). This abnormal karyotype showed derivative chromosome 5 resulting from an insertion of a segment 3q25q29 from the long arm of chromosome 3 into the long arm of chromosome 5 at band 5q31. The segment is replaced by translocation of a segment 12p12.2 from the short arm of chromosome 12 to the chromosome 3 at band 3q24. This three way translocations has been confirmed by FISH using WCP for chromosome 3, 5 and 12 (Figure 2).
CCRs are very rare events in the human population that can be inherited or de novo and can be balanced or imbalanced. Balanced CCRs can lead to an unbalanced condition of gametes during meiosis. Most de novo CCRs originate from spermatogenesis and cause mental retardation in high incidence, whereas most familial CCRs are of maternal origin and usually have three to four breakpoints [2]. This proband had CCRs with 4 chromosomal breakpoints and involved three chromosomes. The abnormal features in this present case might be attributable to gene disruption, cryptic imbalances and/or from position effects of genes. Recently, FISH with specific DNA probes for whole chromosomes or for indicated specific chromosomal segments, has significantly improved the characterization of CCRs [3]. Â Although FISH contributes in elucidating the complexity of CCR, painting FISH is limited in detecting submicroscopic deletions or identifying changes due to gene position effect.
There are several mechanisms that leads to chromosomal rearrangements. A simultaneous double stranded DNA breaks were induced by unknown stimulus including free radiation or ionizing radiation, followed by joining of the break fragments in the wrong place due to microhomology shared by these regions [1]. The origin of the complex translocation in the present case, whether inherited or de novo, could not be established due to lack of consent of parents for the cytogenetic examination.
References
Hemmat, M., et al., Characterization of a complex chromosomal rearrangement using chromosome, FISH and microarray assays in a girl with multiplecongenital abnormalities and development delay. Molecular Cytogenesis, 2014. 7:50.
Asia, S., et. al., A Rare De Novo Complex Chromosomal Rearrangement (CCR) involving four chromosomes in An Oligo-asternosperm Infertile Man. Cell Journal, 2014. 16(3): p. 377-382.
Kim, S. K., et al., A Case with Balanced Chromosome Rearrangement Involving Chromosomes 9, 14 and 13 in a Woman with Recurrent Abortion. Yonsei Medical Journal, 2001. 42(3): p. 345-348.
Downloads
Published
Issue
Section
License
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
